Ameet Mallik - Jan 2, 2024 Form 3 Insider Report for ADC Therapeutics SA (ADCT)

Role
Chief Executive Officer, Director
Signature
/s/ Ameet Mallik
Stock symbol
ADCT
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
3
Date filed
1/2/2024, 07:59 PM
Previous filing
Jun 2, 2023
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADCT Common Shares 1.2M Jan 2, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADCT Stock Options (Right to Buy) Jan 2, 2024 Common Shares 1.07M $10.95 Direct F2
holding ADCT Stock Options (Right to Buy) Jan 2, 2024 Common Shares 625K $1.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 990,000 Common Shares to be delivered in settlement of a restricted share unit award ("RSUs") which vests 50% on the one-year anniversary of the grant date, which grant date is December 6, 2023, and on the two-year anniversary of the grant date, and 207,079 RSUs granted on May 2022 which vest 1/3 on each of the first three anniversaries of the grant date. Both awards are subject to continued service through the designated vesting event.
F2 This option vests over four years from May 6, 2022, with 1/4 vesting on the first anniversary of such date, and the remainder vesting monthly in 36 equal installments, subject to continued service through each such vesting date.
F3 This option vests over four years from March 22, 2023, with 1/4 vesting on the first anniversary of such date, and the remainder vesting monthly in 36 equal installments, subject to continued service through each such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney